Headline News about Pfizer![]() ![]()
Pfizer's Problems Go Far Beyond Just Declining COVID Revenue
February 07, 2024
Via The Motley Fool
Exposures
COVID-19
![]() Via Benzinga
![]() ![]() ![]()
Spotlight on Pfizer: Analyzing the Surge in Options Activity
February 05, 2024
Via Benzinga
![]()
Is the Worst Over for Pfizer?
February 01, 2024
Via The Motley Fool
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Biden Administration To Send Pharma Companies Opening Offers For Medicare Program's First Ever Drug Price Negotiations
February 02, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
![]() ![]() ![]() ![]()
Pfizer Surprises With Profit But Revolutionizing Cancer Treatment Is Its Best Chance Of Getting Back In The Saddle
February 01, 2024
Via Benzinga
Exposures
COVID-19
![]() ![]()
Biotech And Medtech Portfolio Notes On A Fed Day
January 31, 2024
Via Talk Markets
Topics
Economy
Exposures
Interest Rates
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|